Losartan not found to reduce lung injury and mortality in patients with COVID-19

Researchers at University of Minnesota have found that a common blood pressure medication — losartan — is not effective in reducing lung injury in patients with COVID-19. Further it had no effect on...

Related Keywords

Michael Puskarich , Christopher Tignanelli , Melinda Gates Foundation , School Of Public Health , M Medical School , Public Health , Melinda Gates , Losartan , Educe , Lung Injury , Nd Mortality , Covid 19 , Lama , Journal Of American Medical Association ,